This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $79,283.85 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to supply...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
This is a $43,228.97 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract is for the "A. PILLAY ILLUMINA PROJECT" with a completion date of October 12, 2022. Illumina has a history of providing sequencing systems, consumables, and related services to support genomic research and diagnostics for various federal agencies like the NIH,...
This is a purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents. The $137,112.53 firm fixed price contract is for the delivery of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems and related consumables and services to support genomic research and diagnostics for various federal agencies, including the National...
This is a $80,453.34 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract is for the provision of reagent products to support the CDC's genomic sequencing and analysis work. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, USDA, and VA for research and diagnostics. This award does not have...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...